Guardian Pharmacy Services, Inc. (NYSE:GRDN - Get Free Report)'s share price dropped 5.4% during trading on Tuesday . The stock traded as low as $20.00 and last traded at $20.12. Approximately 111,487 shares changed hands during trading, a decline of 29% from the average daily volume of 157,774 shares. The stock had previously closed at $21.26.
Guardian Pharmacy Services Stock Down 1.8 %
The stock's 50-day moving average is $20.56.
Institutional Investors Weigh In On Guardian Pharmacy Services
Hedge funds and other institutional investors have recently made changes to their positions in the company. R Squared Ltd purchased a new stake in Guardian Pharmacy Services during the fourth quarter worth $30,000. Investment Research & Advisory Group Inc. purchased a new stake in shares of Guardian Pharmacy Services during the 4th quarter worth about $34,000. BNP Paribas Financial Markets acquired a new stake in shares of Guardian Pharmacy Services during the 4th quarter valued at about $37,000. Compass Financial Services Inc purchased a new position in shares of Guardian Pharmacy Services in the 4th quarter valued at about $58,000. Finally, JPMorgan Chase & Co. acquired a new position in Guardian Pharmacy Services in the 4th quarter worth about $77,000.
Guardian Pharmacy Services Company Profile
(
Get Free Report)
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.
Further Reading
Before you consider Guardian Pharmacy Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Guardian Pharmacy Services wasn't on the list.
While Guardian Pharmacy Services currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
